Abstract:Using an engineered pyrrolysyl-tRNA synthetase mutant together with tRNACUAPyl, we have genetically encoded Nε-(7-azidoheptanoyl)-l-lysine (AzHeK) by amber codon in Escherichia coli for recombinant expression of a number of AzHeK-containing histone H3 proteins. We assembled in vitro acyl-nucleosomes from these recombinant acyl-H3 histones. All these acyl-nucleosomes contained an azide functionality that allowed quick click labeling with a strained alkyne dye for in-gel fluorescence analysis. Using these acyl-nucleosomes as substrates and click labeling as a detection method, we systematically investigated chromatin deacylation activities of SIRT7, a class III NAD+-dependent histone deacylase with roles in aging and cancer biology. Besides confirming the previously reported histone H3K18 deacylation activity, our results revealed that SIRT7 has an astonishingly high activity to catalyze deacylation of H3K36 and is also catalytically active to deacylate H3K37. We further demonstrated that this H3K36 deacylation activity is nucleosome dependent and can be significantly enhanced when appending the acyl-nucleosome substrate with a short double-stranded DNA that mimics the bridging DNA between nucleosomes in native chromatin. By overexpressing SIRT7 in human cells, we verified that SIRT7 natively removes acetylation from histone H3K36. Moreover, SIRT7-deficient cells exhibited H3K36 hyperacetylation in whole cell extracts, at rDNA sequences in nucleoli, and at select SIRT7 target loci, demonstrating the physiologic importance of SIRT7 in determining endogenous H3K36 acetylation levels. H3K36 acetylation has been detected at active gene promoters, but little is understood about its regulation and functions. Our findings establish H3K36 as a physiologic substrate of SIRT7 and implicate this modification in potential SIRT7 pathways in heterochromatin silencing and genomic stability.

Revealing chromatin-specific functions of histone deacylases

The Zinc-Dependent HDACs: Non-Histone Substrates and Catalytic Deacylation Beyond Deacetylation.

Competitive or noncompetitive, that's the question: research toward histone deacetylase inhibitors

Unravelling HDAC Selectivity for Erasing Acetyl Mark on Lys‐5 of Histone H2B

Targeting histone deacetylases: Emerging applications beyond cancer

Histone Deacetylases in Metabolism: The Known and the Unexplored

Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases

Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases

Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability

CHAPTER 7. Targeting Non-Acetylation Histone Erasers

Class I histone deacetylases (HDAC1–3) are histone lysine delactylases

The pivotal role of histidine 976 in human histone deacetylase 4 for enzyme function and ligand recognition

A short guide to histone deacetylases including recent progress on class II enzymes

Roles of Histone Deacetylases in Epigenetic Regulation: Emerging Paradigms from Studies with Inhibitors

Endogenous expression of inactive lysine deacetylases reveals deacetylation-dependent cellular mechanisms

Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design

A Click Chemistry Approach Reveals the Chromatin-Dependent Histone H3K36 Deacylase Nature of SIRT7.

Histone deacetylase complexes: Structure, regulation and function

Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases

Discovery of de novo Macrocycle Inhibitors of Histone Deacetylase 11

HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation